Roxana Schillaci

2.6k total citations
58 papers, 1.9k citations indexed

About

Roxana Schillaci is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Roxana Schillaci has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 27 papers in Molecular Biology and 17 papers in Immunology. Recurrent topics in Roxana Schillaci's work include Cytokine Signaling Pathways and Interactions (18 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and HER2/EGFR in Cancer Research (12 papers). Roxana Schillaci is often cited by papers focused on Cytokine Signaling Pathways and Interactions (18 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and HER2/EGFR in Cancer Research (12 papers). Roxana Schillaci collaborates with scholars based in Argentina, United States and Chile. Roxana Schillaci's co-authors include Patricia V. Elizalde, María F. Mercogliano, Cecilia J. Proietti, Eduardo H. Charreau, Martín A. Rivas, Sofía Bruni, Wendy Béguelin, Cinthia Rosemblit, Mariana Salatino and Romina P. Carnevale and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Roxana Schillaci

57 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roxana Schillaci Argentina	26	896	855	428	375	312	58	1.9k
Patricia V. Elizalde Argentina	28	1.1k 1.2×	1.0k 1.2×	478 1.1×	317 0.8×	489 1.6×	60	2.1k
Yong Wen United States	16	1.9k 2.2×	1.0k 1.2×	481 1.1×	350 0.9×	344 1.1×	23	2.9k
Henry B. Sadowski United States	17	1.0k 1.1×	946 1.1×	322 0.8×	501 1.3×	383 1.2×	23	2.2k
Laura Moro Italy	23	1.1k 1.3×	436 0.5×	225 0.5×	190 0.5×	270 0.9×	55	2.2k
Andrea Sacchetti Netherlands	25	1.2k 1.3×	821 1.0×	401 0.9×	249 0.7×	317 1.0×	50	2.4k
Anindita Bhoumik United States	25	1.8k 2.0×	508 0.6×	506 1.2×	310 0.8×	238 0.8×	34	2.4k
Makoto Katsumata United States	21	825 0.9×	476 0.6×	140 0.3×	738 2.0×	307 1.0×	48	1.8k
Gianluca Bossi Italy	30	1.4k 1.5×	988 1.2×	547 1.3×	254 0.7×	144 0.5×	53	2.2k
Sripathi M. Sureban United States	28	1.3k 1.5×	1.2k 1.4×	598 1.4×	199 0.5×	217 0.7×	51	2.5k
Janet H. Scott United States	24	762 0.9×	687 0.8×	424 1.0×	197 0.5×	79 0.3×	49	1.9k

Countries citing papers authored by Roxana Schillaci

Since Specialization

Citations

This map shows the geographic impact of Roxana Schillaci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxana Schillaci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxana Schillaci more than expected).

Fields of papers citing papers by Roxana Schillaci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxana Schillaci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxana Schillaci. The network helps show where Roxana Schillaci may publish in the future.

Co-authorship network of co-authors of Roxana Schillaci

This figure shows the co-authorship network connecting the top 25 collaborators of Roxana Schillaci. A scholar is included among the top collaborators of Roxana Schillaci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxana Schillaci. Roxana Schillaci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bruni, Sofía, Ernesto Gil Deza, Elmer A. Fernández, et al.. (2025). Mucin 4 expression is associated with metastasis in triple-negative breast cancer and can be tackled by soluble TNF blockade, improving immunotherapy outcome. Translational Oncology. 54. 102325–102325. 1 indexed citations

Izzo, Franco, Violeta A. Chiauzzi, Sofía Bruni, et al.. (2022). Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer. Cell Death and Disease. 13(5). 447–447. 9 indexed citations

Moiola, Cristian P., María F. Mercogliano, Roxana Schillaci, et al.. (2019). FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways. Frontiers in Oncology. 9. 1306–1306. 18 indexed citations

Mercogliano, María F., Mara De Martino, Leandro Venturutti, et al.. (2016). TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer. Clinical Cancer Research. 23(3). 636–648. 81 indexed citations

Russo, Rosalía I. Cordo, Wendy Béguelin, María C. Díaz Flaqué, et al.. (2014). Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance. Oncogene. 34(26). 3413–3428. 42 indexed citations

Gasparoto, Thaís Helena, Carine Ervolino de Oliveira, Juliana I. Hori, et al.. (2014). Inflammasome Activation Is Critical to the Protective Immune Response during Chemically Induced Squamous Cell Carcinoma. PLoS ONE. 9(9). e107170–e107170. 22 indexed citations

Izzo, Franco, María F. Mercogliano, Leandro Venturutti, et al.. (2014). Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth. Breast Cancer Research. 16(6). 491–491. 27 indexed citations

Tkach, Mercedes, Cinthia Rosemblit, Martín A. Rivas, et al.. (2013). p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth. Endocrine Related Cancer. 20(2). 197–212. 77 indexed citations

Schillaci, Roxana, Pablo Guzmán, Florencia Cayrol, et al.. (2012). Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer. BMC Cancer. 12(1). 74–74. 33 indexed citations

10.

Rivas, Martín A., Leandro Venturutti, Yi‐Wen Huang, et al.. (2012). Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. Breast Cancer Research. 14(3). R77–R77. 92 indexed citations

11.

Flaqué, María C. Díaz, Rocío Vicario, Cecilia J. Proietti, et al.. (2012). Progestin drives breast cancer growth by inducing p21CIP1 expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2. Steroids. 78(6). 559–567. 20 indexed citations

12.

Béguelin, Wendy, María C. Díaz Flaqué, Cecilia J. Proietti, et al.. (2010). Progesterone Receptor Induces ErbB-2 Nuclear Translocation To Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3. Molecular and Cellular Biology. 30(23). 5456–5472. 85 indexed citations

13.

Proietti, Cecilia J., Wendy Béguelin, María C. Díaz Flaqué, et al.. (2010). Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer. Steroids. 76(4). 381–392. 23 indexed citations

14.

Proietti, Cecilia J., Cinthia Rosemblit, Wendy Béguelin, et al.. (2008). Stat3 enhances Progesterone Receptor (PR)-mediated transcriptional activity through Sp-1 in the p21 promoter in breast cancer cells.. Cancer Research. 68. 3021–3021. 1 indexed citations

15.

Rivas, Martín A., Romina P. Carnevale, Cecilia J. Proietti, et al.. (2007). TNFα acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-κB-dependent pathways. Experimental Cell Research. 314(3). 509–529. 133 indexed citations

16.

Schillaci, Roxana, Mariana Salatino, Juliana Cassataro, et al.. (2006). Immunization with Murine Breast Cancer Cells Treated with Antisense Oligodeoxynucleotides to Type I Insulin-Like Growth Factor Receptor Induced an Antitumoral Effect Mediated by a CD8+ Response Involving Fas/Fas Ligand Cytotoxic Pathway. The Journal of Immunology. 176(6). 3426–3437. 25 indexed citations

17.

Schillaci, Roxana, et al.. (2005). Autocrine/paracrine involvement of insulin‐like growth factor‐I and its receptor in chronic lymphocytic leukaemia. British Journal of Haematology. 130(1). 58–66. 27 indexed citations

18.

Salatino, Mariana, Roxana Schillaci, Cecilia J. Proietti, et al.. (2004). Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity. Oncogene. 23(30). 5161–5174. 52 indexed citations

19.

Salatino, Mariana, Letícia Labriola, Roxana Schillaci, Eduardo H. Charreau, & Patricia V. Elizalde. (2001). Mechanisms of Cell Cycle Arrest in Response to TGF-β in Progestin-Dependent and -Independent Growth of Mammary Tumors. Experimental Cell Research. 265(1). 152–166. 8 indexed citations

20.

Schillaci, Roxana, Elsie M. Eugui, & Alicia Roldán. (1994). Insulin Effect on Interleukin 1 (IL-1) and Interleukin 6 (IL-6) Production by Lipopolysaccharide-Stimulated Human Monocytes. Hormone and Metabolic Research. 26(2). 113–115. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact